According to top market research analysts, the Sickle Cell Disease market to grow steadily at a CAGR of 0.85% from 2015-2025 in 6MM (excluding Japan). United States contributes the major share of Sickle Cell Disease market as compared to EU5 countries. The therapeutic market of Sickle Cell Disease in 6MM is expected to reach USD 3.1 Billion in 2025 at the good CAGR value from 2015-2025. The higher prevalence of Sickle Cell Disease in United States is attributed to the immigration of majority of African population in the United States.
The Sickle Cell Disease (SCD) Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of Sickle Cell Disease, epidemiology and market trends of the Sickle Cell Disease for the United States and EU5 (Germany, Spain, Italy, France and United Kingdom). The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Sickle Cell Disease from 2017 to 2025 segmented by seven major markets. In addition, the report also includes the forecasted epidemiology of Sickle Cell Disease till 2025.The Report also covers market drivers, market barriers and unmet medical need.
Greater uptake by the three emerging novel drugs Endari (Emmaus Lifesciences), GBT-440 (GBT Therapeutics), and Crizanlizumab (Novartis) will primarily drive the SCD market. As the number of effective treatments for the Sickle Cell Disease increase in the market during the forecast period, the prescription medications (HU; Iron Chelators, Analegesics, Antibiotics, vaccines) market share will start to decrease. Emmauss Endari will be the preferred therapy for the complications associated with SCD owing to its less cost, which will give more patient access to this therapy.
Key Coverage and Benefits: 1. The report will help in developing business strategies by understanding the trends shaping and driving the global Sickle Cell Disease market. 2. Organize sales and marketing efforts by identifying the best opportunities for Sickle Cell Disease in US and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom). 3. To understand the future market competition in the Sickle Cell Disease market and Insightful review of the key market drivers and barriers. 4. The report provides historical as well as forecasted epidemiology of Sickle Cell Disease in the 6MM covering United States and EU5 (Germany, Spain, Italy, France and United Kingdom) from 2015-2025. 5. The Report also covers the detailed historical and forecasted Sickle Cell Disease market covering United States and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) from 2015-2025.
Global Sickle Cell Disease Market Report 2017 1. Report Summary 2. Sickle Cell Disease Market Overview at a Glance 3. Disease Background and Overview: Sickle Cell Disease 4. Epidemiology and Patient Population 5. Prevalent Population of Sickle Cell Disease in 6MM 6. Epidemiology of Sickle Cell Disease 7. United States 7.1. Assumptions and Rationale 7.2. Prevalent Population of Sickle Cell Disease in United States ..Continue. 15. Specific pain management 16. Supportive care: Oxygen therapy 17. Hydration: Fluid replacement 18. Antibiotics 19. Transfusions 20. First line treatment 21. Hydroxyurea 22. Bone marrow transplantation 23. Current Unmet needs 24. Marketed Drugs for Sickle Cell Disease 25. Emerging Drugs for Sickle Cell Disease 26. Failed Therapies 27. Sickle Cell Disease (SCD): Market Analysis 28. United States 28.1. Market Size of Sickle Cell Disease (SCD) in United States ..Continue. 35. Market Drivers 36. Market Barriers 37. Appendix 38. Report Methodology 39. Consulting Services 40. Disclaimer 41. About DelveInsight
About us: Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario. Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
